MAY 27, 2021 7:00 AM PDT

Breakthrough Diagnostic Detects TB Infections in Infants Sooner

WRITTEN BY: Tara Fernandez

There are nearly a million cases of tuberculosis (TB) every year, and over 80 percent of childhood deaths from TB occur in those under 5 years old. A new diagnostic technology could help reduce the death toll from childhood TB. The test, created by researchers at Tulane University, looks for a protein called CFP-10 that is produced by Mycobacterium tuberculosis, the bacteria that causes TB infections. The assay can be performed on a small blood sample.

“This is a breakthrough for infants with tuberculosis because we don’t have this kind of screening technology to catch early infections among those youngest groups who are most likely to be undiagnosed,” said Tony Hu, lead author of the study published in BMC Medicine. “I hope this method can be pushed forward quickly to reach these children as early as possible.”

Current TB tests (mycobacterial culture and molecular diagnostic assays) rely on respiratory samples that are particularly difficult to obtain in infants and small children. Even if they are successfully obtained, samples from infected children contain significantly fewer bacteria than those from adults, meaning they are prone to receiving false-negative results.

CFP-10 is present in minute amounts in the circulation, but the assay developed by Hu and colleagues uses antibodies against the protein to separate it from the abundance of other proteins present in the blood. Mass spectrometry, a highly sensitive analytical technique that measures the mass of different molecules within a sample, is then used to accurately detect the presence of CFP-10.

In the study, Hu and colleagues used the new assay to screen samples from over 280 HIV-infected and 235 healthy children. The new test matched results from the current gold standard with 100% accuracy and additionally, detected 83.7 percent of TB cases that previously received false-negative results with standard tests.

On a positive note, the test alerted to the presence of TB in 77 percent of blood samples collected around 5 months before the children were diagnosed using other techniques. In some cases, the tests were able to pick up CFP-10 as early as a year before an official diagnosis.

As the next steps, Hu and colleagues are working towards a cost-effective, portable device that can perform the assay outside of a laboratory setting.

 

 

Source: Tulane University, BMC Medicine.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 08, 2021
Microbiology
Authorities Work to Contain Nipah Virus Outbreak in India
SEP 08, 2021
Authorities Work to Contain Nipah Virus Outbreak in India
Nipah virus is one of the world's deadliest viruses. It has caused several small outbreaks in Southeast Asia since it em ...
OCT 21, 2021
Clinical & Molecular DX
Dementia Diagnostic Looks for 'Hungry' Immune Cells in the Brain
OCT 21, 2021
Dementia Diagnostic Looks for 'Hungry' Immune Cells in the Brain
Experts have long known that the immune cells in our brains called microglia are important for preserving neural tissue ...
OCT 19, 2021
Clinical & Molecular DX
Air Surveillance Technology Sniffs Out Coronaviruses in the Room
OCT 19, 2021
Air Surveillance Technology Sniffs Out Coronaviruses in the Room
Imagine walking into a party where people were socializing (unmasked) in a confined space. With the ongoing pandemic not ...
NOV 02, 2021
Clinical & Molecular DX
No More Antibodies: COVID Test Uses Glowing Nanotubes
NOV 02, 2021
No More Antibodies: COVID Test Uses Glowing Nanotubes
Forget expensive antibody-based COVID diagnostics and long waits for test results. An innovative new approach developed ...
NOV 14, 2021
Microbiology
Beneficial Bacteria May Help Fight Ear Infections Caused by Bacterial Pathogens
NOV 14, 2021
Beneficial Bacteria May Help Fight Ear Infections Caused by Bacterial Pathogens
Researchers have identified bacteria that have the potential to fight infections that affect the middle ear and can caus ...
NOV 25, 2021
Clinical & Molecular DX
Cactus Spines Inspire Diagnostic Tools Without the Prick
NOV 25, 2021
Cactus Spines Inspire Diagnostic Tools Without the Prick
Did you know that there are over 1700 species of cacti—spiny plants that have evolved to survive some of the harsh ...
Loading Comments...